Company Filing History:
Years Active: 2005-2010
Title: Fabienne Soubrier: Innovator in Gene Therapy
Introduction
Fabienne Soubrier is a prominent inventor based in Thiais, France. She has made significant contributions to the field of gene therapy, holding a total of 4 patents. Her work focuses on the development of circular DNA molecules that have conditional origins of replication, which are crucial for advancing therapeutic techniques.
Latest Patents
One of her latest patents describes a circular DNA molecule that is useful for gene therapy. This molecule comprises at least one nucleic acid sequence of interest and features a region that allows replication with an origin of replication requiring the presence of a specific protein foreign to the host cell. Additionally, she has developed a method for preparing these DNA molecules, as well as cells that incorporate them for use in gene therapy. Another patent details a prokaryotic recombinant host cell that includes a heterologous replication initiation protein, which activates a conditional origin of replication. This innovation also involves an extrachromosomal DNA molecule containing a heterologous therapeutic gene, emphasizing the importance of specific proteins in the replication process.
Career Highlights
Throughout her career, Fabienne Soubrier has worked with notable companies such as Centelion and Aventis Pharma S.A. Her expertise in gene therapy has positioned her as a key figure in the development of innovative therapeutic solutions.
Collaborations
One of her notable collaborators is Joël Crouzet, with whom she has worked on various projects related to her patents and innovations.
Conclusion
Fabienne Soubrier's contributions to gene therapy through her innovative patents and collaborations highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in therapeutic applications.